(Q52423367)

1 May 2018

title

Doxazosin in the treatment of essential hypertension in general medical practice in Latin America (English)

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90867-H

Cardiology and cardiovascular medicine

3 December 2022

main subject

essential hypertension

1 reference

based on heuristic

inferred from title

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90867-H

3 December 2022

author name string

H. Silva

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1824656

3 December 2022

R. Fonseca

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1824656

3 December 2022

D. Marshall

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1824656

3 December 2022

language of work or name

English

0 references

publication date

1 January 1991

1 reference

1 May 2018

full work available at URL

https://api.elsevier.com/content/article/PII:000287039190867H?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90867-H

https://api.elsevier.com/content/article/PII:000287039190867H?httpAccept=text/plain

3 December 2022

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90867-H

3 December 2022

published in

American Heart Journal

1 reference

1 May 2018

volume

121

1 reference

1 May 2018

issue

1 Pt 2

1 reference

1 May 2018

page(s)

329-335

1 reference

1 May 2018

Multicentre 12-week double-blind comparison of doxazosin, prazosin and placebo in patients with mild to moderate essential hypertension

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90867-H

A multicenter study of doxazosin in the treatment of severe essential hypertension

3 December 2022

2

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90867-H

The alpha 1-adrenoceptor antagonist profile of doxazosin: preclinical pharmacology

3 December 2022

3

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90867-H

A comparison of the effects of doxazosin and alfuzosin with those of urapidil on preganglionic sympathetic nerve activity in anaesthetised cats

3 December 2022

4

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90867-H

Pharmacokinetic overview of doxazosin

3 December 2022

5

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90867-H

Clinical pharmacological studies with doxazosin

3 December 2022

6

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90867-H

Determination of the vasodilator UK33274 by high-performance liquid chromatography using fluorescence detection

3 December 2022

7

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90867-H

Clinical pharmacology of doxazosin in patients with essential hypertension.

3 December 2022

8

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90867-H

Doxazosin, an alpha 1-adrenoceptor antagonist: pharmacokinetics and concentration-effect relationships in man

3 December 2022

9

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90867-H

Serum lipid changes in a one-year, multicenter, double-blind comparison of doxazosin and atenolol for mild to moderate essential hypertension

3 December 2022

12

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90867-H

Plasma lipid lowering effects of doxazosin, a new selective alpha1 adrenergic inhibitor for systemic hypertension

3 December 2022

13

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90867-H

A multicenter trial of doxazosin in West Germany

3 December 2022

14

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90867-H

Stratifying the patient at risk from coronary disease: new insights from the Framingham Heart Study.

3 December 2022

16

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90867-H

Treatment of the elderly hypertensive: a clinical perspective

3 December 2022

17

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90867-H

A pharmacodynamic and pharmacokinetic assessment of a new alpha- adrenoceptor antagonist, doxazosin (UK33274) in normotensive subjects

3 December 2022

18

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90867-H

Multicenter, double-blind comparison of doxazosin and atenolol in patients with mild to moderate hypertension

3 December 2022

19

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90867-H

3 December 2022

Identifiers

1 reference

1 May 2018

1 reference

1 May 2018